SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042652
Filing Date
2021-08-09
Accepted
2021-08-09 16:17:19
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20210630.htm   iXBRL 10-Q 2916344
2 EX-31.1 rgnx-ex311_6.htm EX-31.1 16936
3 EX-31.2 rgnx-ex312_8.htm EX-31.2 16907
4 EX-32.1 rgnx-ex321_7.htm EX-32.1 11295
  Complete submission text file 0001564590-21-042652.txt   10783593

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210630.xsd EX-101.SCH 58650
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20210630_cal.xml EX-101.CAL 62955
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20210630_def.xml EX-101.DEF 189436
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210630_lab.xml EX-101.LAB 452831
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210630_pre.xml EX-101.PRE 338719
10 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-10q_20210630_htm.xml XML 2523307
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 211156722
SIC: 2836 Biological Products, (No Diagnostic Substances)